Texas Permanent School Fund Enanta Pharmaceuticals Inc Transaction History

Texas Permanent School Fund

$597 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$20.68 - $39.85 $3,887 - $7,491	-188 Reduced 1.07%	17,419 $372,000
Q1 2023 May 01, 2023	BUY	$38.82 - $54.59 $175,078 - $246,200	4,510 Added 34.44%	17,607 $712,000
Q4 2022 Feb 07, 2023	SELL	$40.77 - $53.73 $37,467 - $49,377	-919 Reduced 6.56%	13,097 $609,000
Q3 2022 Oct 25, 2022	BUY	$48.29 - $71.27 $33,416 - $49,318	692 Added 5.19%	14,016 $727,000
Q2 2022 Aug 08, 2022	BUY	$38.13 - $76.93 $14,680 - $29,618	385 Added 2.98%	13,324 $630,000
Q1 2022 May 06, 2022	SELL	$56.06 - $74.11 $1,737 - $2,297	-31 Reduced 0.24%	12,939 $921,000
Q4 2021 Feb 08, 2022	SELL	$60.19 - $97.37 $20,404 - $33,008	-339 Reduced 2.55%	12,970 $970,000
Q3 2021 Oct 28, 2021	SELL	$41.02 - $58.65 $3,486 - $4,985	-85 Reduced 0.63%	13,309 $756,000
Q2 2021 Jul 27, 2021	SELL	$43.76 - $53.11 $831 - $1,009	-19 Reduced 0.14%	13,394 $589,000
Q1 2021 May 03, 2021	SELL	$41.69 - $54.95 $39,021 - $51,433	-936 Reduced 6.52%	13,413 $662,000
Q4 2020 Feb 04, 2021	SELL	$41.16 - $47.47 $96,232 - $110,984	-2,338 Reduced 14.01%	14,349 $604,000
Q3 2020 Nov 06, 2020	BUY	$43.36 - $53.53 $168,453 - $207,964	3,885 Added 30.35%	16,687 $764,000
Q2 2020 Aug 04, 2020	SELL	$46.37 - $57.58 $35,102 - $43,588	-757 Reduced 5.58%	12,802 $643,000
Q1 2020 Apr 27, 2020	BUY	$40.22 - $62.0 $105,778 - $163,060	2,630 Added 24.06%	13,559 $697,000
Q4 2019 Feb 03, 2020	BUY	$57.95 - $66.61 $4,520 - $5,195	78 Added 0.72%	10,929 $675,000
Q3 2019 Oct 31, 2019	BUY	$60.08 - $88.17 $2,283 - $3,350	38 Added 0.35%	10,851 $652,000
Q2 2019 Aug 09, 2019	BUY	$81.3 - $97.35 $9,756 - $11,682	120 Added 1.12%	10,813 $912,000
Q1 2019 May 02, 2019	BUY	$69.08 - $105.66 $27,424 - $41,947	397 Added 3.86%	10,693 $1.02 Million
Q4 2018 Feb 11, 2019	BUY	$65.41 - $84.65 $27,472 - $35,553	420 Added 4.25%	10,296 $729,000
Q3 2018 Oct 22, 2018	BUY	$85.46 - $126.37 $46,917 - $69,377	549 Added 5.89%	9,876 $844,000
Q2 2018 Jul 23, 2018	SELL	$81.85 - $120.51 $14,896 - $21,932	-182 Reduced 1.91%	9,327 $1.08 Million
Q1 2018 Apr 20, 2018	SELL	$57.91 - $92.15 $8,223 - $13,085	-142 Reduced 1.47%	9,509 $769,000
Q4 2017 Jan 23, 2018	SELL	$45.65 - $59.37 $35,241 - $45,833	-772 Reduced 7.41%	9,651 $566,000
Q3 2017 Nov 13, 2017	BUY	$37.91 - $46.8 $395,135 - $487,796	10,423	10,423 $488,000

Others Institutions Holding ENTA

# of Institutions

108

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$11.1 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$10.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$9.7 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$7.86 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$5.79 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.

Account